Styrene

Styrene

SCHEMBL5469787

C=Cc1ccccc1.N#CCC(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TSHR P16473 1/20 0.52
PAM P19021 2/20 0.44
MCL1 Q07820 3/20 0.42
LMNA P02545 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 1/20 0.37
RCE1 Q9Y256 1/20 0.37
POLB P06746 1/20 0.36
PLIN1 O60240 2/20 0.36
PLIN5 Q00G26 2/20 0.36
ABHD5 Q8WTS1 2/20 0.36
RECQL P46063 2/20 0.36
NPC1 O15118 2/20 0.36
KDM4E B2RXH2 1/20 0.36
AKT1 P31749 1/20 0.35
HDAC3 O15379 1/20 0.35
TNKS O95271 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Styrene SCHEMBL27725386 0.80 ALDH1A1 (0.74) ALDH1A1TSHRMCL1LMNASMN1; SMN2
Styrene SCHEMBL9011439 0.80 ALDH1A1 (0.74) ALDH1A1TSHRPAMMCL1LMNA
Styrene SCHEMBL4375720 0.79 ALDH1A1 (0.58) ALDH1A1TSHRPAMMCL1LMNA
Styrene SCHEMBL5859639 0.78 ALDH1A1 (0.64) ALDH1A1TSHRPAMMCL1LMNA
Styrene SCHEMBL26133544 0.78 ALDH1A1 (0.64) ALDH1A1TSHRPAMLMNAMEN1
Styrene SCHEMBL5480221 0.78 ALDH1A1 (0.64) ALDH1A1TSHRPAMLMNASMN1; SMN2
Biphenyl SCHEMBL31235587 0.78 MCL1 (0.48) ALDH1A1TSHRMCL1LMNASMN1; SMN2
Styrene SCHEMBL27928437 0.78 ALDH1A1 (0.70) ALDH1A1TSHRMCL1LMNASMN1; SMN2
Styrene SCHEMBL27636982 0.78 ALDH1A1 (0.70) ALDH1A1TSHRMCL1LMNASMN1; SMN2
Styrene SCHEMBL27849673 0.78 ALDH1A1 (0.70) ALDH1A1TSHRMCL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110536944-A Formaldehyde-free curable compositions ROHM & HAAS 2019-12-03 CN disclosed
US-20070014756-A1 Composition and method for treating the gastro-intestinal tract TOUCHOT NICHOLAS 2007-01-18 US disclosed
US-20040191318-A1 Composition and method for treating the gastro-intestinal tract VILLITECH SARL (FR) 2004-09-30 US disclosed
EP-1462116-A1 Composition for treating the gastrointestinal tract Villitech SARL (FR) 2004-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070014756-A1 Composition and method for treating the gastro-intestinal tract GIPR, FABP2, FABP6 ALDH1A1 3713/4885TSHR 334/4885PAM 298/4885
US-20040191318-A1 Composition and method for treating the gastro-intestinal tract GIPR, FABP2, FABP6 ALDH1A1 3713/4885TSHR 334/4885PAM 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.